Clinical Trials Logo

Diabetic Foot Osteomyelitis clinical trials

View clinical trials related to Diabetic Foot Osteomyelitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06010433 Not yet recruiting - Clinical trials for Diabetic Foot Osteomyelitis

CERAMENT G Device Registry

Start date: September 22, 2023
Phase:
Study type: Observational [Patient Registry]

This is an Observational Device Registry Study of CERAMENT|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that is reflective of 'real world' device performance.

NCT ID: NCT05539963 Recruiting - Clinical trials for Diabetic Foot Osteomyelitis

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.

BLADE-VG2
Start date: January 23, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to evaluate the safety and between-group effect size of STIMULAN VG compared to SoC treatment in patients with diabetic foot osteomyelitis (DFO) of the forefoot.

NCT ID: NCT05177107 Recruiting - Osteomyelitis Clinical Trials

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

DANCE
Start date: November 24, 2021
Phase: Phase 2
Study type: Interventional

This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.

NCT ID: NCT04240964 Completed - Microbiome Clinical Trials

Studying on the Difference Between Two Kinds of Osteomyelitis

Start date: July 1, 2017
Phase:
Study type: Observational

To explore the microbial differences of diabetic foot osteomyelitis and osteomyelitis without diabetes.

NCT ID: NCT04041739 Not yet recruiting - Clinical trials for Diabetic Foot Osteomyelitis

Fungal Infection in Patients With Diabetic Foot Osteomyelitis

Start date: January 2020
Phase:
Study type: Observational

estimate the percentage of fungal infection in the pathogenesis of diabetic foot osteomyelitis and assess the outcome of patients with fungal diabetic foot osteomyelitis

NCT ID: NCT02927678 Recruiting - Clinical trials for Diabetic Foot Osteomyelitis

White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis

Start date: January 2014
Phase: N/A
Study type: Observational

Osteomyelitis is a risk factor for lower extremity amputation in diabetic people. Antibiotic therapy allows a remission in 60 to 80% of cases. However the optimal duration of antibiotic therapy remains controversy due to the absence of validated marker of osteomyelitis remission. We have previously shown that the negativity of white blood cell SPECT/CT (Single Photon Emission Computed Tomography/Computed Tomography) imaging at the end of treatment allowed to predict remission of osteomyelitis at 1 year in all cases. A positive imaging was associated with recurrence in 70% of cases. The aim of our study was to evaluate prospectively the interest of white blood cell SPECT/CT to set the duration of antibiotic therapy.